Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6497)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2018 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ochi M, Kamoshida T, Ohkawara A, Ohkawara H, Kakinoki N, Hirai S, Yanaka A. Multikinase inhibitor-associated hand-foot skin reaction as a predictor of outcomes in patients with hepatocellular carcinoma treated with sorafenib. World J Gastroenterol 2018; 24(28): 3155-3162 [PMID: 30065561 DOI: 10.3748/wjg.v24.i28.3155] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i28/3155.htm |
| Number | Citing Articles |
| 1 |
Shou-Sheng Chu, Yu-Hsuan Kuo, Wen-Shan Liu, Shih-Chang Wang, Chung-Han Ho, Yi-Chen Chen, Ching-Chieh Yang, Hung-Chang Wu. Effect of radiotherapy on survival in advanced hepatocellular carcinoma patients treated with sorafenib: a nationwide cancer-registry-based study. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-81176-w
|
| 2 |
Aminah Jatoi, Fang-Shu Ou, Daniel H. Ahn, Tyler J. Zemla, Jennifer G. Le-Rademacher, Patrick Boland, Kristen K. Ciombor, Nisha L. Jacobs, Boris Pasche, James M. Cleary, Jeannine S. McCune, Katrina S. Pedersen, Afsaneh Barzi, E. Gabriela Chiorean, Erica N. Heying, Heinz-Josef Lenz, Jeff A. Sloan, Axel Grothey, Mario E. Lacouture, Tanios Bekaii-Saab. Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial. The Oncologist 2021; 26(7): 610 doi: 10.1002/onco.13730
|
| 3 |
Xuan Qiu, Manjiang Li, Liqun Wu, Yang Xin, Siyu Mu, Tianxiang Li, Kangjian Song. <p>Severe Fatigue is an Important Factor in the Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib</p>. Cancer Management and Research 2020; : 7983 doi: 10.2147/CMAR.S233448
|
| 4 |
Álvaro Díaz‐González, Marco Sanduzzi‐Zamparelli, Víctor Sapena, Ferran Torres, Neus LLarch, Gemma Iserte, Alejandro Forner, Leonardo da Fonseca, José Ríos, Jordi Bruix, María Reig. Systematic review with meta‐analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib. Alimentary Pharmacology & Therapeutics 2019; 49(5): 482 doi: 10.1111/apt.15088
|
| 5 |
Masanori Ochi, Toshiro Kamoshida, Masahiro Araki, Tadashi Ikegami. Prolonged survival in patients with hand-foot skin reaction secondary to cooperative sorafenib treatment. World Journal of Gastroenterology 2021; 27(32): 5424-5437 doi: 10.3748/wjg.v27.i32.5424
|
| 6 |
Yuka Aimono, Noriko Kohyama, Toshiro Kamoshida, Toshinori Yamamoto, Mari Kogo. QOL Assessment in Chronic Hepatitis C Patients Receiving Ledipasvir/ Sofosbuvir or Simeprevir/Peginterferon/Ribavirin in Clinical Practice. YAKUGAKU ZASSHI 2019; 139(11): 1427 doi: 10.1248/yakushi.19-00019
|